Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15774 articles
Prognostic and predictive impact of MGMT promoter methylation status in high risk grade II glioma.
mMGMT patients had greater median overall survival.
»
12/22/21
Chaperone-mediated autophagy controls proteomic and transcriptomic pathways to maintain glioma stem cell activity.
Clinical samples of GBM tissue presented with overexpression of LAMP2.
»
01/27/22
Thyroid hormone and androgen signals mutually interplay and enhance inflammation and tumorigenic activation of tumor microenvironment in prostate cancer.
Intracellular TH metabolism crucial determinant of PCa behavior.
»
07/28/21
Prognostic and Clinicopathological Significance of Lymph Node Metastasis in the Esophagogastric Junction Adenocarcinoma.
Only independent prognostic factor lymph node metastasis.
»
11/18/21
Is the presence of tumor-infiltrating lymphocytes predictive of outcomes in patients with melanoma?
Presence of TILs significantly prognostic of improved MSS.
»
10/05/21
A Novel Molecular Target in
EGFR
-mutant Lung Cancer Treated With the Combination of Osimertinib and Pemetrexed.
Osimertinib+pemetrexed treatment delayed emergence of resistance relative to monotherapy.
»
11/14/21
The projected impact of the COVID-19 lockdown on breast cancer deaths in England due to the cessation of population screening: a national estimation.
Estimated 148-687 additional breast cancer deaths may have occurred.
»
06/14/21
High parity is associated with increased risk of cervical cancer: Systematic review and meta-analysis of case-control studies.
Women with high parity had 2.65 times higher odds of developing cervical cancer.
»
02/04/22
Intravesical Bacillus Calmette-Guerin (BCG) Therapy for Non-muscle Invasive Bladder Cancers: Long-term Results of a Modified Schedule.
5-year recurrence-free survival was 83%.
»
10/23/20
Molecular Characterization and Therapeutic Targeting of Colorectal Cancers Harboring Receptor Tyrosine Kinase Fusions.
Identified 12 driver oncogenic fusions in various RTKs.
»
10/15/20
< Prev
Next >